Your browser doesn't support javascript.
loading
PYY plays a key role in the resolution of diabetes following bariatric surgery in humans.
Guida, Claudia; Stephen, Sam D; Watson, Michael; Dempster, Niall; Larraufie, Pierre; Marjot, Thomas; Cargill, Tamsin; Rickers, Lisa; Pavlides, Michael; Tomlinson, Jeremy; Cobbold, Jeremy F L; Zhao, Chun-Mei; Chen, Duan; Gribble, Fiona; Reimann, Frank; Gillies, Richard; Sgromo, Bruno; Rorsman, Patrik; Ryan, John D; Ramracheya, Reshma D.
Afiliación
  • Guida C; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
  • Stephen SD; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
  • Watson M; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
  • Dempster N; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
  • Larraufie P; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Marjot T; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
  • Cargill T; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
  • Rickers L; Oxford Bariatric Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Pavlides M; Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, UK; Oxford NIHR Biomedical Research Centre, Oxford, UK.
  • Tomlinson J; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
  • Cobbold JFL; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
  • Zhao CM; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Chen D; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Gribble F; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Reimann F; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Gillies R; Oxford Bariatric Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Sgromo B; Oxford Bariatric Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Rorsman P; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
  • Ryan JD; Translational Gastroenterology Unit, University of Oxford, Oxford, UK. Electronic address: john.ryan@ndm.ox.ac.uk.
  • Ramracheya RD; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK. Electronic address: Reshma.ramracheya@ocdem.ox.ac.uk.
EBioMedicine ; 40: 67-76, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30639417
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptido YY / Diabetes Mellitus Tipo 2 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: EBioMedicine Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptido YY / Diabetes Mellitus Tipo 2 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: EBioMedicine Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido